Canada Pension Plan Investment Board Argenx Se Transaction History

Canada Pension Plan Investment Board

  • $98.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$108.83 - $165.23 $182,834 - $277,586
-1,680 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$106.59 - $164.21 $179,071 - $275,872
1,680 New
1,680 $270,000
Q2 2019

Aug 12, 2019
SELL
$115.0 - $141.58 $233,450 - $287,407
-2,030 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$98.85 - $134.59 $200,665 - $273,217
2,030 New
2,030 $253,000

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email